Kang, 2003 - Google Patents
- ️Wed Jan 01 2003
Kang, 2003
-
Document ID
- 2567764548394409378 Author Publication year
- 2003
External Links
Snippet
Voltage-activated Ca 2+ channels are important components for fundamental neurophysiological processes in the brain such as neurotransmission, neurosecretion, and development. To understand Ca 2+ channels function in the brain, this study analyzed the …
- 230000001537 neural 0 title abstract description 163
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9406—Neurotransmitters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wu et al. | 2010 | SLEEPLESS, a Ly-6/neurotoxin family member, regulates the levels, localization and activity of Shaker |
Beech et al. | 2003 | TRPC1 store-operated cationic channel subunit |
Klugbauer et al. | 2003 | Calcium channel α 2 δ subunits: Differential expression, function, and drug binding |
US5364842A (en) | 1994-11-15 | Method of producing analgesia |
Ahlijanian et al. | 1990 | Subunit structure and localization of dihydropyridine-sensitive calcium channels in mammalian brain, spinal cord, and retina |
Hervieu et al. | 2001 | Distribution and expression of TREK-1, a two-pore-domain potassium channel, in the adult rat CNS |
Kaczmarek | 2013 | Slack, slick, and sodium‐activated potassium channels |
Garcia et al. | 1995 | Charybdotoxin and its effects on potassium channels |
Moss et al. | 2002 | The novel product of a five‐exon stargazin‐related gene abolishes CaV2. 2 calcium channel expression |
Steiner et al. | 2004 | Reticulon 1‐C/neuroendocrine‐specific protein‐C interacts with SNARE proteins |
US7138248B2 (en) | 2006-11-21 | Method of inhibiting inward rectifier, G-protein activated, mammalian, potassium channels and uses thereof |
Osorio et al. | 2010 | Persistent Nav1. 6 current at axon initial segments tunes spike timing of cerebellar granule cells |
Tanemoto et al. | 2002 | PSD-95 mediates formation of a functional homomeric Kir5. 1 channel in the brain |
Chien et al. | 2006 | Single Cl− channels activated by Ca2+ in Drosophila S2 cells are mediated by bestrophins |
Jerusalinsky et al. | 2000 | Muscarinic toxins: novel pharmacological tools for the muscarinic cholinergic system |
Toulmé et al. | 2007 | An intracellular motif of P2X3 receptors is required for functional cross‐talk with GABAA receptors in nociceptive DRG neurons |
Moss et al. | 2003 | Human neuronal stargazin-like proteins, γ 2, γ 3 and γ 4; an investigation of their specific localization in human brain and their influence on Ca V 2.1 voltage-dependent calcium channels expressed in Xenopus oocytes. |
Jones et al. | 2016 | Single amino acid deletion in transmembrane segment D4S6 of sodium channel Scn8a (Nav1. 6) in a mouse mutant with a chronic movement disorder |
Jones et al. | 1992 | Muscarinic acetylcholine receptors |
CA2802207A1 (en) | 2012-01-19 | Materials and method for suppressing inflammatory and neuropathic pain |
Carlier et al. | 2000 | Effect of maurotoxin, a four disulfide‐bridged toxin from the chactoid scorpion Scorpio maurus, on Shaker K+ channels |
Kang | 2003 | Structure and modulation of neuronal high voltage-activated calcium channel complex |
Chernova et al. | 2005 | Expression of the polycystin-1 C-terminal cytoplasmic tail increases Cl-channel activity in Xenopus oocytes |
Wick et al. | 1999 | Stable expression of human glycine α1 and α2 homomeric receptors in mouse L (tk−) cells |
US20090176651A1 (en) | 2009-07-09 | A H+-Gated Ion Channel |